AMG 510: A Potent KRAS G12C Inhibitor for Targeted Cancer Therapy
Explore the cutting-edge potential of AMG 510, a key player in next-generation cancer treatment and research.
Get a Quote & SampleProduct Core Value
AMG 510
AMG 510, identified by CAS 2252403-56-6, represents a significant advancement in targeted cancer therapy. This high-quality pharmaceutical intermediate is a potent inhibitor of the KRAS G12C mutation, a common driver in various cancers.
- Discover how to buy AMG 510 online from reliable pharmaceutical intermediate suppliers in China for your research needs.
- Learn about the critical role of CAS 2252403-56-6 in the identification and procurement of this vital compound.
- Understand the potential of KRAS G12C inhibitor cancer treatment in improving patient outcomes.
- Explore the development journey of sotorasib for lung cancer and its therapeutic implications.
Key Advantages
Precision Targeting
AMG 510 offers precise targeting of the KRAS G12C mutation, a crucial factor in developing effective cancer therapies.
High Purity Intermediate
As a high-quality pharmaceutical intermediate supplier, we ensure that AMG 510 meets stringent purity standards for advanced research.
Therapeutic Potential
The development of sotorasib highlights the significant therapeutic potential of KRAS G12C inhibitors in combating various forms of cancer.
Key Applications
Oncology Drug Development
AMG 510 serves as a vital component in the development of novel oncology drugs, offering new avenues for cancer treatment.
Cancer Treatment Research
Researchers leverage this KRAS G12C inhibitor for in-depth studies into cancer mechanisms and treatment strategies.
Pharmaceutical Research
Its status as a pharmaceutical intermediate makes it indispensable for researchers in the pharmaceutical sector exploring new treatments.
Targeted Therapy Advancement
AMG 510 contributes to the advancement of targeted therapy, offering hope for more effective and less toxic cancer interventions.